Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin vs Metformin vs Combination in Newly Diagnosed Type 2 Diabetes Mellitus with PCOS
ChiCTR-IPR-17011120Phase 4Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of saxagliptin and metformin in type 2 diabetes mellitus (T2DM) and polycystic ovary syndrome (PCOS) (3 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoints: Height, Weight and 9 more. Started Aug 2012; status: completed.
02
Drugs
saxagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR-IPR-17011120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011120.